Skip to content

Public FDA record

Z-0673-2024: Boston Scientific Model 3120 ZOOM LATITUDE Programmer/Recorder/Monitor (PRM) installed with Model 2892 Pr

Recall record Z-0673-2024 for Boston Scientific Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0673-2024
Company in FDA record
Boston Scientific Corporation
FDA classification date
Jan 5, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The software application on the Programmer/Recorder/Monitor (PRM) for Implantable Pulse Generators will display certain diagnostic dates incorrectly, with a year in the 1990s.

Source facts

Action
The recalling firm issued letters flagged "Important Medical Device Information" dated 30 November 2023 to Dear Physician or Healthcare Professional (HCP) via Federal Express or courier with signed receipt in the U.S. on 11/30/2023. The letter provides a description of unanticipated behavior and clinical impact and provides a recommendation to keep the letter with all Model 3120 programmers at their center or distribute the letter to all HCPs who perform pacemaker checks using a Model 3120 ZOOM programmer. When using the Model 2892 software application on the programmer, if a date includes a year in the 1990s, the HCPs may (1) determine a precise date by interrogating an ALTRUA, INSIGNIA, or NEXUS pacemaker with a Model 3300 LATITUDE programmer; or (2) determine an approximate date (within a two-day range) using the table in Appendix A of the letter. (Appendix A is a table listing the incorrectly displayed date in the 1990s and what the approximate date should be if the date was displayed correctly.) The addressee is informed that Boston Scientific does not recommend prophylactic replacement of pacemakers due to incorrect dates. An acknowledgement form is enclosed for completion and return.
Initiated
2023-11-30
Root cause
Under Investigation by firm
Distribution
Distribution was nationwide, including Guam, Puerto Rico, and the U.S. Virgin Islands. There was also government/military distribution. Foreign distribution was made to Andorra, Argentina, Aruba, Australia, Austria, Bahamas, Bahrain, Bangladesh, Belarus, Belgium, Benin, Bermuda, Bolivia, Bosnia and Herzegovina, Brazil, British Virgin Islands, Bulgaria, Cameroon, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Faroe Islands, Finland, France, French Polynesia, Germany, Great Britain, Greece, Guatemala, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Korea, Kuwait, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Macedonia, Madagascar, Malaysia, Malta, Mauritius, Mexico, Morocco, Namibia, Netherlands, Netherlands Antilles, New Zealand, Nicaragua, Norway, Oman, Pakistan, Palestine, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Fed., San Marino, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, South Yemen, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Taiwan R.O.C., Thailand, Trinidad and Tobago, Tunisia, Turkey, Uganda, Ukraine, United Arab Emirates, Uruguay, Venezuela, Vietnam, and Zimbabwe.
Recall number
Z-0673-2024
Recall status
Open, Classified
CDRH record ID
204639
FDA classified
2024-01-05
Recall event number
93519

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗